{"name":"Vance Thompson Vision","slug":"vance-thompson-vision","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Ophthalmology","slug":"ophthalmology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Kera Sol Eye Drops","genericName":"Kera Sol Eye Drops","slug":"kera-sol-eye-drops","indication":"Dry eye disease / Keratoconjunctivitis sicca","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"TetraLens bandage contact lens","genericName":"TetraLens bandage contact lens","slug":"tetralens-bandage-contact-lens","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Kera Sol Eye Drops","genericName":"Kera Sol Eye Drops","slug":"kera-sol-eye-drops","phase":"marketed","mechanism":"Kera Sol Eye Drops is a lubricating ophthalmic solution designed to provide moisture and relief to dry eyes.","indications":["Dry eye disease / Keratoconjunctivitis sicca"],"catalyst":""},{"name":"TetraLens bandage contact lens","genericName":"TetraLens bandage contact lens","slug":"tetralens-bandage-contact-lens","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNNUh2T3hfN0NBbEJVWnI5YVZZWGRfbDY5OGxReWNDcUdRandjRGJlVkhEU21OYmQ5UWR2MGhPak9KdVRqSUNMNTZsd2JrOGw5Y0pvVHVYVkRNT1JMc1pkdWhzMzhkUWQxNUZCMWdoOHYxOXZOb21lZlR3a0loMEltY3JzeHRYQQ?oc=5","date":"2026-02-24","type":"pipeline","source":"SiouxFalls.Business","summary":"Former Allure Health building to be new home for medical spa - SiouxFalls.Business","headline":"Former Allure Health building to be new home for medical spa","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPUzBOY1YxTThPcHR3ZUFrTnhrRVlfNXVMeTlzTWNnS1VOUGFkbzlRdXZMb3BtNW5mX1F1YWJycUFIamtLamROU2JGNDhZUTZSU2g1dFhEc3hjUUdJQjJmb3dkc01TWjU1UWdHWXlYVURCSUhhX2JvcG45aVJmM1lJX2hkdUVtdFJ1QTFocWNMYjlwRXR0anJpNVBQUHRhNm4wc05DOUxwTkl1VVNhS2Q3MG5na0tzTHVxVDAzOHFRbHJhZw?oc=5","date":"2026-01-30","type":"pipeline","source":"Healio","summary":"Qlosi reduces pupil diameter with no significant impact on ciliary muscle - Healio","headline":"Qlosi reduces pupil diameter with no significant impact on ciliary muscle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVXV5bEppQngyZ3pIcE5jMTJ6VUkxNzM1cGhDb0FtS29SeHhBTndQaHNkOTFjN0FWcVZPbXlxYTRTSERuLUlMRm5PRXBXWEpxblFFRHRWbURHa0Zid19ic01FelhqQlM1ZUZISXE4eGR5aTU4aC1wdlo4STJuNk9tWlNMVkt2VmZ2TDhIX2pBTDVZa0xSRlpBYXk3aFd4bU02dnA2NVVaWHFnZw?oc=5","date":"2025-11-18","type":"pipeline","source":"Eyes On Eyecare","summary":"TearOptix secures funding for presbyopia MF lens tech - Eyes On Eyecare","headline":"TearOptix secures funding for presbyopia MF lens tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNcHplYVNONzZlWlRTX282NEsyTTc5MWNRall4cjA4Skxja0ZoV21KRUJtMmVKXzZvMHRlUTZkS0hLMnQ2eHNrQW9GMXF0YXFwa3RIeXVRNE90RkJTa0xIdDNGbHpuaTVsQzk1UUlFU0NGLThmdmxuSEMwWDNfZVplLXVlcGl4RE5qalRMZEJhNk1JZmZMNXk0VUdDd0pycnh4YVFLRDdDNjV6Tk53a25KX0Nn?oc=5","date":"2025-09-16","type":"pipeline","source":"Medical Design & Outsourcing","summary":"Eye surgeons identify three critical ophthalmology innovation needs - Medical Design & Outsourcing","headline":"Eye surgeons identify three critical ophthalmology innovation needs - Medical Design & Outsourcing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQWC01TkFrQzdqUDZ4MW4tVGRTdkFILUlLNlRHdFk3LVRpQlFZcGRQLUxUNU1MSTVnVEF5LVBscmhnQmp2UmM3QUxxUjZGMDNxbXdwTE50ZHJuMGh5SlJmb1VwMnRNWmpydnFfRVRtcVVPMjRYOEZFTG80T1RMbGJPTGZHYzFFRU9DRVB1MHlYN3hBVUo0Z2cyWlQtdVBILXBy?oc=5","date":"2025-07-15","type":"pipeline","source":"EyeWorld","summary":"Nuances of the Light Adjustable Lens in specific patient populations - EyeWorld","headline":"Nuances of the Light Adjustable Lens in specific patient populations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOOThhaXAwNV8wek4ydlQxMmxnVHRDNVRTVXpIQjQxLUt0RktnMHU5aHQzblVOT2JTWFhCNC1Pd2hNLXpMckxxYWFIcWxyNGxRaFhKd3VfSzF5WS13Ulp0U3dKWFVrUjlTcmtIOUFGb0xaT2lwaWhXZmUyS21WeUh3M1JTNFAxakxYNV9oODViZzB3SkNZNUYyLXA1VlJLUjlfdUM4SzlyNzJMTzBSR19udVB3R0ZWcnhidEZrWk5UYw?oc=5","date":"2025-06-23","type":"pipeline","source":"Healio","summary":"Three is a magic number when it comes to new dry eye disease treatments - Healio","headline":"Three is a magic number when it comes to new dry eye disease treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxPYTN0Q1JEWXJkaVJpYmdvRklIU1lhODNFekJWd0R6WDRmcUNQcmIzWDBjNXZZblozaXFBU0puY0VUY2dnU2dBdjVaZ0JkRl92a1ZsUUgxZG9QVWZwWlMwUHp1V2EwWlA2LVdYZkhLbXBYZXE4aFAzRmVvZU9OTlFKODlhR3k4WGY4SGNPWGZxRW9INkJIQjlXS1FJb2ZKVDEtV1ZXc1hhY0p4REpWVllLcGtGaXBPSTlNa2VEM25CTXZ2aU9mNTQtdURfUGF5X2JhZ1hFejA0UC1jM0twSnZXVlhqREctSnFBYy1MNDRPOXY5ODlpSVhmbnU2TQ?oc=5","date":"2025-06-17","type":"pipeline","source":"BioSpace","summary":"Amaros Closes Series A Financing, Expands Advisory Board to Accelerate Market Entry of the EvidenceEngine™ Ophthalmic AI Platform - BioSpace","headline":"Amaros Closes Series A Financing, Expands Advisory Board to Accelerate Market Entry of the EvidenceEngine™ Ophthalmic AI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPVkpyWnhCVl9sOFVKWFRpOW9OSEp6VjZqSDJUSXJEQ3hya19aLVRZWW5MMzRsR0hPTFMtSHZlX2tkNTBfOGFmcnVLeUoxNnIya3NUMVBfMHI2SlExR20xXzdhU29hNm1Bd3pXOVZ2cEUtZjYzWTRJZmxxU2VDTjhfR21rQmpUUFZqSUc0TkVJQTZzNGZ6em9aN2ZOb1pOTWZLSVRQdVhZYXAtQWl0a3g3Qw?oc=5","date":"2025-06-04","type":"regulatory","source":"Optometry Times","summary":"iVeena submits IND to FDA for a phase 2 clinical trial for pediatric myopia - Optometry Times","headline":"iVeena submits IND to FDA for a phase 2 clinical trial for pediatric myopia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPUGFNdjFZOTFGVzJTSWFXSnpKQ2lFb1NHN0FDOFowVVBadi1FYjlKRlpqcXRTaU93aTNzcXk2Q2dWR1preGxQdXd0Ym9qc09pelFrLTkxeGF2WERfS1FpWTdXMlFLVW9GY0sySEwwLWhVcnpXSlBVazRXTF9PRDNnd2gzVFFCeWFEbUFwNUlqNXpMbkhJZm1oZkF6aTZOZVB0SUR5NzktWmNHenhpdzZsTkY3NnJOeTlhamc?oc=5","date":"2024-10-23","type":"pipeline","source":"Ophthalmology Times Europe","summary":"AAO 2024: An oral anaesthetic offers relief for both patients and care teams - Ophthalmology Times Europe","headline":"AAO 2024: An oral anaesthetic offers relief for both patients and care teams","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPSVoxZGw4ZVk5ZGlPWjUzNk1Wd09LeTJTTU81ZGpXR1VMT2daQnVYMU93bXRLTXNtUTE2bFdoTlllM05KbWdac2t4ZWd4cnVhWnhVVEZNdXljeS1OQk9Memd5OG85RksyU3U3ZXFWMk9BeGd0Tk5BQ1NmWVVKcWZWdVdvUF9Db3B5NzRncA?oc=5","date":"2024-02-15","type":"pipeline","source":"Association of periOperative Registered Nurses | AORN","summary":"What’s Best for Eye Surgery Sedation? - Association of periOperative Registered Nurses | AORN","headline":"What’s Best for Eye Surgery Sedation? - Association of periOperative Registered Nurses | AORN","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQYmFGZGgta3FtV2FmSC1ncXN6YWd3eEVINXFfOFdTcWtHQkhtc2Q5Q1hFQ1JYMUtSVllJX0RzeHgzS3daRlBvM0RSZ2RuWVV3YnNvOVpfUGREMkxRN1ZwT1lHczMwenp4NXBxX2lxZ1RWMll0d3ZmTWtHemg1OUEyY0N3?oc=5","date":"2021-11-01","type":"pipeline","source":"American Academy of Ophthalmology","summary":"Presbyopia-Correcting Eyedrops Move Ahead - American Academy of Ophthalmology","headline":"Presbyopia-Correcting Eyedrops Move Ahead","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxObUdiNFkyZmJVSlpWZERSQzBjOXEwSTUxd01fMWlQMHVacVpudFpMNTRuWnJkSGotVmpTbWZSR1dmZEZ1RmpvdFpfVGZrRUlPY1gxRlpLTUVIbUgtb3lWclVUZHUyUWIzZVVGY2t5NTIxTUxXZU5TVk5FNEItVmJ5UDk0RW8waG5waWV5Q2hGM0Zuc1FBbWRyVVZiRkIwVlhYRnVjTGVmNkZhQnhxVEQtbERrWEx0NmZxWDEzYXprSmlHU2QzNXNjYnEzdmhwQnhSUHllWkNHdWJpN3dUZHU0cmU5Zw?oc=5","date":"2019-11-26","type":"pipeline","source":"PR Newswire","summary":"Vance Thompson Vision growth in Omaha, NE leads to acquisition of Nebraska Laser Eye Institute - PR Newswire","headline":"Vance Thompson Vision growth in Omaha, NE leads to acquisition of Nebraska Laser Eye Institute","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":1,"phase_1":1},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}